Welcome to our dedicated page for IVEDA SOLUTIONS SEC filings (Ticker: IVDAW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings for Iveda Solutions, Inc. (NASDAQ: IVDA, IVDAW) provide official details on the company’s corporate actions, securities, and Nasdaq listing status. These documents include current reports on Form 8-K and other required submissions that describe events such as warrant issuances, shareholder approvals and communications with The Nasdaq Stock Market LLC regarding continued listing requirements.
In one Form 8-K, Iveda reported that a majority of its outstanding shareholders approved the issuance of Series A and Series B common stock purchase warrants and the shares of common stock underlying those warrants, with the voting results presented in the filing. This type of disclosure helps investors understand how new warrants are authorized and the terms under which they may be exercised.
Another Form 8-K describes a letter from the Listing Qualifications Department of Nasdaq granting Iveda an extension to regain compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market under Listing Rule 5550(b)(1). The filing outlines the background of the non-compliance notice, the extension period and the potential consequences, including possible delisting and the availability of an appeal process under Nasdaq rules.
Earlier company communications also discuss a private placement of common stock and warrants pursuant to a securities purchase agreement with institutional investors, including the planned filing of registration statements covering the resale of the shares of common stock and shares issuable upon exercise of the warrants. Related registration rights and offering details are typically addressed in filings with the Securities and Exchange Commission.
On this SEC filings page, users can access Iveda’s public filings as they appear on the SEC’s EDGAR system, including annual and quarterly reports when filed, current reports on Form 8-K, and documents related to warrant issuances and capital raises. AI-powered tools can assist by summarizing key points, such as the nature of material events, the structure of warrant and equity offerings, and updates on listing compliance, helping readers interpret the regulatory disclosures associated with IVDA and IVDAW.
Iveda Solutions, Inc. received an institutional ownership filing showing that entities affiliated with Iroquois Capital report meaningful positions in its common stock. Iroquois Capital Management LLC reports beneficial ownership of 500,000 shares, representing 4.5% of the common stock, with shared voting and dispositive power over these shares.
Richard Abbe reports beneficial ownership of 714,286 shares, or 6.4% of the class, combining 214,286 shares over which he has sole voting and dispositive power with 500,000 shares over which he shares authority. Kimberly Page reports beneficial ownership of 500,000 shares, or 4.5%, with shared voting and dispositive power.
The filing notes additional warrants held by related entities that are exercisable for up to 1,000,000 and 428,572 shares for certain funds, and 1,428,572 shares for Mr. Abbe, but these are currently blocked by 4.99% Beneficial Ownership Blockers. Based on a prospectus indicating 11,139,740 shares outstanding as of the completion of a recent offering, the reported percentages reflect these blockers. The reporting persons certify that the securities are not held for the purpose of changing or influencing control of Iveda Solutions.
Iveda Solutions, Inc. has filed an amended S-1 to offer up to 5,434,782 shares of common stock, together with up to 5,434,782 pre-funded warrants and up to 5,434,782 Series X warrants to buy up to 10,869,564 additional shares, on a reasonable best efforts basis. The assumed combined price is $0.92 per share and accompanying Series X warrants, matching the last Nasdaq Capital Market close on January 28, 2026.
The company, recently redomiciled to Delaware, develops AI-driven video analytics and IoT-based smart city platforms, with most revenue generated by its Taiwan subsidiary. It has a going concern opinion, accumulated losses of about $51 million through December 31, 2024, and relies heavily on a small number of key customers. There is no minimum offering amount or escrow, so investor funds become immediately available even if limited capital is raised, and the new securities will dilute existing holders, with common shares outstanding rising from 5,879,741 to 11,314,523 if all shares (but no warrants) are sold.
Iveda Solutions, Inc. is conducting a reasonable best efforts primary offering of up to 5,434,782 shares of common stock at an assumed combined price of $0.92 per share together with Series X warrants to purchase up to 10,869,564 additional shares. The company may instead issue up to 5,434,782 pre-funded warrants in lieu of common stock for investors constrained by 4.99% or 9.99% ownership limits, with each pre-funded warrant exercisable at $0.0001 per share.
The Series X warrants are exercisable upon issuance at $0.92 per share and expire two years after issuance. Common stock outstanding was 5,879,741 shares before the offering and is expected to be 11,314,523 shares after the offering, excluding existing options and warrants. Iveda highlights significant risks, including a going concern opinion, accumulated losses of roughly $51–53 million, heavy reliance on its Taiwan subsidiary for most revenue, customer concentration, and the possibility of Nasdaq delisting if listing standards are not maintained.
Iveda Solutions, Inc. reconvened its 2024 Annual Meeting of Stockholders on August 29, 2025, where stockholders approved the issuance of new common stock purchase warrants. A total of 1,409,415 shares entitled to vote, representing 58.5% of the company’s outstanding voting capital stock as of the October 7, 2024 record date, were present in person or by proxy, constituting a quorum.
Stockholders approved Proposal 5 to issue 625,000 Series A Common Stock Purchase Warrants and 625,000 Series B Common Stock Purchase Warrants, each with an exercise price of $3.44 per common share, along with the shares of common stock issuable upon exercise of these warrants. The proposal received 1,253,925 votes for, 121,349 votes against, and 34,141 abstentions.